NASDAQ:IDRA - Nasdaq - US45168K4058 - Common Stock - Currency: USD
Idera Pharmaceuticals (IDRA) fell ~22% Tuesday after the company said that a 1-for-17 reverse stock split of common stock would take effect tomorrow at the open. Read the full story here.
Gainers
Acquisition includes late-stage rare disease portfolio with anticipated 2023 clinical milestones and first potential product approval as early as late 2024...
EXTON, Pa., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported...
Good morning, trader! We're starting off the week with an overview of the biggest pre-market stock movers for Monday morning!
– Enrollment Stopped Early for Efficacy –...
EXTON, Pa., May 05, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its...
EXTON, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported...
Penny stocks to buy for under $2
We're at the halfway point of the week but there's no slowing down as we dive into the biggest pre-market stock movers for Wednesday!
EXTON, Pa., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” and “our”) (Nasdaq: IDRA) today announced...